ApoPharma's Preemptive Safety Strategy For Ferriprox Includes Centralized Pharmacy Distribution

ODAC will consider Ferriprox (deferiprone) as second-line treatment for transfusional iron overload; the company hopes for an endorsement of its patient and provider registries as well.